Equities

Clearside Biomedical Inc

Clearside Biomedical Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.8798
  • Today's Change-0.048 / -5.17%
  • Shares traded237.58k
  • 1 Year change-47.32%
  • Beta2.0926
Data delayed at least 15 minutes, as of Mar 10 2025 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Monday, Clearside Biomedical Inc (CLSD:NMQ) closed at 0.8798, 13.71% above the 52 week low of 0.7737 set on Mar 03, 2025.
52-week range
Today
0.7737Mar 03 20252.12Mar 12 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.8868
High0.916
Low0.8603
Bid0.875
Offer0.9135
Previous close0.9278
Average volume292.17k
Shares outstanding75.84m
Free float70.32m
P/E (TTM)--
Market cap70.37m USD
EPS (TTM)-0.4503
USD
Data delayed at least 15 minutes, as of Mar 10 2025 20:00 BST.
More ▼

Events & Activity

  • CLSD:NMQ price falls below 50-day moving average to 0.9122 at 08:00 BST
  • CLSD:NMQ price moved over +6.30% to 0.8504
  • CLSD:NMQ price falls below 50-day moving average to 0.9203 at 09:42 GMT
  • CLSD:NMQ price rises above 50-day moving average to 0.955 at 11:27 GMT
  • CLSD:NMQ trading volume exceeds daily average by +48.43%
  • CLSD:NMQ price falls below 15-day moving average to 0.9122 at 08:00 BST
  • CLSD:NMQ price falls below 15-day moving average to 0.9203 at 09:42 GMT
  • CLSD:NMQ price rises above 15-day moving average to 0.94 at 11:23 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.